Chemical company with pharmaceutical focus buys biotech company

Chemical company with pharmaceutical focus buys biotech company

Viruses have not only had a bad reputation since the appearance of Corona – they are generally regarded as rapidly spreading pathogens. However, there are also viruses that have a positive medical effect – recently researched and used in biotechnology. One company that has turned its attention to this is Labor Dr. Merk & Kollegen (LMK) in Ochsenhausen near Biberach. LMK was recently taken over by Boehringer Ingelheim, one of the largest chemical companies in the world and one of the largest companies in Germany. This article is based on the unique List of the 600 largest chemical companies in Germany.

  • Article based on database of the 600 most important chemical companies in Germany
  • Detailed information on the field of activity (transport logistics, warehouse logistics, industrial logistics, pharmaceutical logistics, food logistics, port logistics, etc.)
  • Including: sales (2015-2018), number of employees, e-mail, address, telephone number, management, etc.
  • Direct download as Excel file via the ResearchGermany online store possible
  • Free preview file available on request

Viruses in the fight against cancer – a development with a future

Labor Dr. Merk & Kollegen has been involved in virology since 1971. Only a few years ago, the business was refocused – on so-called viral therapeutics. In gene and virotherapies (oncolytic viruses), tumour vaccines and CAR-T cell therapies, viruses are specifically used for disease control and immunisation. For example, they are designed to act as tumor cell killers in certain cancer therapies or are used in vaccines. The new applications belong to the market for innovative advanced therapy solutions – called Advanced Therapies Medicinal Products (ATMP). The market is predicted to have great growth potential.

With the LMK acquisition, Boehringer Ingelheim secures a good position in this promising field. The company is to be fully integrated into the group. The approximately 130 LMK employees will continue to be employed as a separate development unit within the group. A particular advantage is that LMK’s headquarters in Ochsenhausen are located in the immediate vicinity of Boehringer Ingelheim’s largest research and development site in Biberach. Boehringer Ingelheim is considered the largest research-based pharmaceutical company in Germany. The business consists mainly of human pharmaceuticals – prescription medicines and the industrial customer business (biopharmaceuticals, pharmaceutical production, pharmaceutical chemicals) – as well as preparations for animal health.
Source: Businesswire Image source: Unsplash

Chemical company from Oldenburg invests in start-upIn our industry report of the German chemical industry you will find detailed information on areas of activity, an overview of the locations and clusters of the chemical sector, key financial figures as well as insights into the gender distribution and sustainability efforts of the sector.

 

You might like these lists of biggest companies and investors:


Leave a Reply

Your email address will not be published. Required fields are marked *